<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04513444</url>
  </required_header>
  <id_info>
    <org_study_id>20 GENE 07</org_study_id>
    <nct_id>NCT04513444</nct_id>
  </id_info>
  <brief_title>Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy</brief_title>
  <acronym>HYPNOMUSE</acronym>
  <official_title>Phase II Study Aiming to Evaluate the Interest of Medical Hypnosis in Anxious Patients Treated by Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Claudius Regaud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut Claudius Regaud</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase II, randomized, non-comparative and monocentric study aims to evaluate the&#xD;
      interest of medical hypnosis in the management of anxiety in patients who are anxious or very&#xD;
      anxious during their radiotherapy treatment.&#xD;
&#xD;
      45 patients will be randomized into the following arms:&#xD;
&#xD;
        -  Arm A (standard): relaxation with music listening during radiotherapy treatment&#xD;
&#xD;
        -  Arm B (experimental): relaxation with music listening and hypnosis during radiotherapy&#xD;
           treatment&#xD;
&#xD;
      For the study each patient will be followed during 2 months.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 7, 2020</start_date>
  <completion_date type="Anticipated">November 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of patients with a change of at least one anxiety level (evolution between the baseline and the 6th and last radiotherapy session)</measure>
    <time_frame>2 months for each patient</time_frame>
    <description>Anxiety will be assessed using the STAI-Y questionnaire (Spielberger State-Trait Anxiety Inventory - State Anxiety form).&#xD;
The following standards will be used to define levels of anxiety:&#xD;
Very high: &gt; 65&#xD;
High: from 56 to 65&#xD;
Average: from 46 to 55&#xD;
Low: 36 to 45&#xD;
Very low: ≤ 35</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety assessed using a numerical scale from 0 to 10 (0 being &quot;not at all anxious&quot; and 10 being &quot;extremely anxious&quot;)</measure>
    <time_frame>2 months for each patient</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed using the EORTC (European Organization for Research and Treatment of Cancer) Quality of life questionnaire (QLQ-C30).</measure>
    <time_frame>2 months for each patient</time_frame>
    <description>Changes in quality of life from baseline will be assessed in the classroom according to the recommendations of the literature (Osoba, JCO).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Solid Tumor</condition>
  <arm_group>
    <arm_group_label>Standard arm (A): music listening therapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental arm (B): music listening and hypnosis therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Relaxation with music listening and medical hypnosis during radiotherapy treatment:</intervention_name>
    <description>Music listening (According to the patient's wishes),&#xD;
Hypnosis sessions with the hypnotherapist during the 1st, 2nd and 3rd radiotherapy session,&#xD;
Self-hypnosis during the 4th and 5th radiotherapy session,&#xD;
Questionnaires (STAI-Y and QLQ-C30) and numerical scales (anxiety and pain) will be completed by patients during radiotherapy consultations.</description>
    <arm_group_label>Experimental arm (B): music listening and hypnosis therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Relaxation with music listening during radiotherapy treatment:</intervention_name>
    <description>Music listening (According to the patient's wishes),&#xD;
Questionnaires (STAI-Y and QLQ-C30) and numerical scales (anxiety and pain) will be completed by patients during radiotherapy consultations.</description>
    <arm_group_label>Standard arm (A): music listening therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥ 18 years at the time of enrollment into the study.&#xD;
&#xD;
          2. Patient with localized or metastatic solid malignant tumor.&#xD;
&#xD;
          3. Patient being followed for the cancer pathology at IUCT-O and to receive, for the&#xD;
             first time in the follow-up, treatment by radiotherapy (radiotherapy treatment should&#xD;
             not have been initiated prior to inclusion in the study).&#xD;
&#xD;
          4. Patient for whom radiotherapy treatment includes at least 15 sessions of radiation&#xD;
             therapy.&#xD;
&#xD;
          5. Patient defined as anxious or very anxious after completing the STAI-Y self-assessment&#xD;
             questionnaire (i.e. ≥ 56 score at inclusion).&#xD;
&#xD;
          6. ECOG patient ≤ 2.&#xD;
&#xD;
          7. Patient who signed informed consent prior to inclusion in the study and prior to any&#xD;
             specific study procedures.&#xD;
&#xD;
          8. Patient affiliated to a Social Health Insurance in France.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient doesn't understand the French language.&#xD;
&#xD;
          2. Patient with psychiatric disorders requiring antidepressant or antipsychotic&#xD;
             treatment.&#xD;
&#xD;
          3. Patient with hearing problems.&#xD;
&#xD;
          4. Pregnant or breastfeeding women.&#xD;
&#xD;
          5. Any psychological, family, geographical or sociological condition that prevents&#xD;
             compliance with the medical follow-up and/or procedures of the study protocol.&#xD;
&#xD;
          6. Patient who has forfeited his/her freedom by administrative or legal award or who is&#xD;
             under legal protection (curatorship and guardianship, protection of justice).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anne DUCASSOU</last_name>
    <phone>05 31 15 54 15</phone>
    <email>ducassou.anne@iuct-oncopole.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institut Universitaire du Cancer de Toulouse - Oncopole</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne DUCASSOU</last_name>
      <phone>05 31 15 54 15</phone>
      <email>ducassou.anne@iuct-oncopole.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2020</study_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Solid Tumor</keyword>
  <keyword>Radiotherapy</keyword>
  <keyword>Hypnosis</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Music listening</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

